Search results for: 'ms 275'
-   B5540 MS 245 oxalateSummary: 5-HT6 antagonist B5540 MS 245 oxalateSummary: 5-HT6 antagonist
-   B5307 CH 275Summary: Potent somatostatin receptor 1 (sst1) agonist B5307 CH 275Summary: Potent somatostatin receptor 1 (sst1) agonist
-   A8171 Entinostat (MS-275,SNDX-275)2 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC1 and HDAC3 inhibitor A8171 Entinostat (MS-275,SNDX-275)2 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC1 and HDAC3 inhibitor
-   B1426 Org 27569Target: CB1 ReceptorsSummary: Cannabinoid CB1 receptor allosteric modulator B1426 Org 27569Target: CB1 ReceptorsSummary: Cannabinoid CB1 receptor allosteric modulator
-   B6996 Ro 08-2750Summary: antagonist of nerve growth factor (NGF) B6996 Ro 08-2750Summary: antagonist of nerve growth factor (NGF)
-   B7346 PF 915275Summary: 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) inhibitor B7346 PF 915275Summary: 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) inhibitor
-   F1704 Anti-B7-H2/ICOSL/CD275 Antibody (Prezalumab)Summary: Anti-B7-H2/ICOSL/CD275 Antibody (Prezalumab) F1704 Anti-B7-H2/ICOSL/CD275 Antibody (Prezalumab)Summary: Anti-B7-H2/ICOSL/CD275 Antibody (Prezalumab)
-   BA6721 PF-03463275Summary: PF-03463275 is a CNS-permeable, orally active, selective, competitive reversible inhibitor of glycine transporter protein-1. BA6721 PF-03463275Summary: PF-03463275 is a CNS-permeable, orally active, selective, competitive reversible inhibitor of glycine transporter protein-1.
-   BA4360 RBN012759Summary: RBN012759 is a potent, selective and orally active inhibitor with values <3nM, 300-fold more selective than for monoPARPs and 1000-fold more selective than for polyPARPs. BA4360 RBN012759Summary: RBN012759 is a potent, selective and orally active inhibitor with values <3nM, 300-fold more selective than for monoPARPs and 1000-fold more selective than for polyPARPs.
-   BA4763 ZEN-2759Summary: An inhibitor. BA4763 ZEN-2759Summary: An inhibitor.
